Top Markets
#1 Siren Siren +39.86%
#2 RedStone RedStone +23.17%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.68%
#4 Perle Perle +15.69%
#5 Ocean Protocol Ocean Protocol +15.26%
#6 KUB Coin KUB Coin +14.31%
#7 Verus Coin Verus Coin +13.51%
#8 Cysic Cysic +10.93%
#9 Nosana Nosana +10.32%
#10 Quack AI Quack AI +10.31%
Coin of the day
Siren Siren
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
Rang în acțiuni #32097
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Preț acțiune
$0.21483059
Ultima sincronizare: 2024-05-07
Capitalizare de piață
$11.13M
Schimbare (1 zi)
0.34%
Schimbare (1 an)
0.00%
Țară
CA
Tranzacționează Antibe Therapeutics Inc. (ATE)

Categorie

Healthcare
Raport P/S pentru Antibe Therapeutics Inc. (ATE)
Raport P/S la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor Antibe Therapeutics Inc., raportul P/S actual (TTM) este 0. La sfârșitul anului 2026, compania avea un P/S de 0.
Istoricul raportului P/S pentru Antibe Therapeutics Inc. din 2026 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
Nu sunt suficiente date pentru perioada selectată.
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.10 -
US